Afatinib and osimertinib in lung adenocarcinoma harbored EGFR T751_I759delinsS mutation: A case report
Abstract Tyrosine kinase inhibitors (TKIs) of epidermal growth factor receptor (EGFR) are the standard treatment for lung cancer patients with activating EGFR mutation. The traditional direct polymerase chain reaction (PCR) has lower sensitivity in the detection of EGFR mutations in patient tissue s...
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2021-12-01
|
| Serier: | Thoracic Cancer |
| Fag: | |
| Online adgang: | https://doi.org/10.1111/1759-7714.14215 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|